Evommune logo

Evommune

Palo Alto, CA

Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.

evommune.com

Company Details

Founded

2020

Employees

Between 20 - 50 employees

Raised

$349,799,936

Headquarters Location

Palo Alto, CA

Public

No

Acquired

No

CEO

Luis PenaLuis Pena

Founders

Luis Pena
Luis Pena
Hans Hofland
Hans Hofland
Eugene Bauer
Eugene Bauer

Company Collections

These are collections Evommune is a part of. Click on the collection name to view similar companies.

Evommune Headquarters Location

Palo Alto, CA 94306

Total Amount Raised: $349,799,936

Evommune Funding Rounds

  • Series Unknown

    $81,799,952

  • Series C

    $115,000,000

    Series C Investors

    RA Capital Management
    Sectoral Asset Management
    Allostery Investments
    Pivotal bioVenture Partners
    ADAR1 Capital Management
    Verition Fund Management
    Amplitude Ventures
    LSP
    B Capital
    Andera Partners
    FemHealth Ventures
    SymBiosis
    Avego Bioscience Capital
    Marshall Wace
    Longwood Fund
    RTW Investments
    NEXTBio Capital
    Oscar & Paul
  • Series B

    $7,500,000

    Series B Investors

    Verition Fund Management
  • Series B

    $50,000,000

    Series B Investors

    Arix Bioscience
    LSP
    SymBiosis
    Amplitude Ventures
    Andera Partners
    Pivotal bioVenture Partners
  • Series A

    $83,000,000

    Series A Investors

    Pivotal bioVenture Partners
    Andera Partners
    LSP BioVentures
  • Seed

    $12,500,000

    Seed Investors

    Pivotal bioVenture Partners
Funding info provided by Diffbot.

Evommune Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Evommune.

Recent reviews